{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T10:57:44Z","timestamp":1773745064010,"version":"3.50.1"},"reference-count":36,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Cincinnati Children's Hospital"},{"name":"Schubert Research Clinic"},{"name":"Center for Clinical & Translational Science & Training"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Turner syndrome (TS) is the most common sex chromosome abnormality in females. Incidence of cardiometabolic complications is high in TS. Obesity and high visceral adiposity (VA) are additional risk factors. Body mass index (BMI) is not the best index of adiposity in TS due to short stature. Dual-energy x-ray absorptiometry (DXA) scan and bioelectrical impedance (BI) could be alternatives. The primary objective is to evaluate alternative methods for body composition assessment in youth with TS. The secondary goal is to characterize body composition and metabolic profiles of youth with TS compared with youth without TS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a cross-sectional study. Participants with TS are on \u226550\u2005mcg transdermal estradiol equivalent replacement or spontaneously menstruating. The control group consisted of youth with normal\/lean BMI and obese BMI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-seven TS, 15 obese, and 15 lean youth were recruited (13-19 years; female). In the TS group, correlation is noted between DXA and BI for fat mass (FM), lean mass (LM), and VA. VA (356.56 +\/\u2212225.82\u2005g) and FM (27.06 +\/\u221211.39\u2005g) from DXA were higher for the TS group compared to the lean group's VA (162.66 +\/\u221268.58\u2005g) and FM (19.44 +\/\u221219.47\u2005g), even with comparable LM and total weight. The prevalence of dyslipidemia was 38% in the TS group. The lean group had no dyslipidemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Differences in LM, FM, and VA would not have been identified by BMI alone. BI may be a convenient and noninvasive outpatient tool in TS to assess body composition and identify risk factors for metabolic dysfunction, such as low LM and high FM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/jendso\/bvag016","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T12:36:37Z","timestamp":1769258197000},"source":"Crossref","is-referenced-by-count":0,"title":["Adipose tissue distribution and metabolic profile of young individuals with turner syndrome"],"prefix":"10.1210","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4273-411X","authenticated-orcid":false,"given":"Varsha Mary","family":"Thomas","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Cincinnati Children's Hospital Medical Center and the University of Cincinnati , Cincinnati, OH 45229 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Backeljauw","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Cincinnati Children's Hospital Medical Center and the University of Cincinnati , Cincinnati, OH 45229 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy Sanghavi","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Cincinnati Children's Hospital Medical Center and the University of Cincinnati , Cincinnati, OH 45229 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Bowers","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Cincinnati Children's Hospital Medical Center and the University of Cincinnati , Cincinnati, OH 45229 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Gutmark-Little","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Cincinnati Children's Hospital Medical Center and the University of Cincinnati , Cincinnati, OH 45229 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"6","key":"2026031705574403300_bvag016-B1","doi-asserted-by":"crossref","first-page":"G53","DOI":"10.1093\/ejendo\/lvae050","article-title":"Clinical practice guidelines for the care of girls and women with turner syndrome","volume":"190","author":"Gravholt","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2026031705574403300_bvag016-B2","doi-asserted-by":"crossref","first-page":"e011501","DOI":"10.1161\/JAHA.118.011501","article-title":"Long-term outcomes in patients with turner syndrome: a 68-year follow-up","volume":"8","author":"Fuchs","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"2026031705574403300_bvag016-B3","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1210\/jc.2008-1049","article-title":"United Kingdom clinical Cytogenetics group. Mortality in women with turner syndrome in Great Britain: a national cohort study","volume":"93","author":"Schoemaker","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026031705574403300_bvag016-B4","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1210\/jc.2006-0558","article-title":"Prevalence, incidence, diagnostic delay, and mortality in turner syndrome","volume":"91","author":"Stochholm","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026031705574403300_bvag016-B5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/ajmg.c.31678","article-title":"Cardiometabolic health in turner syndrome","volume":"181","author":"Davis","year":"2019","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"2","key":"2026031705574403300_bvag016-B6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0895-4356(97)00237-0","article-title":"Morbidity in turner syndrome","volume":"51","author":"Gravholt","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"2026031705574403300_bvag016-B7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fendo.2018.00027","article-title":"The natural history of metabolic comorbidities in turner syndrome from childhood to early adulthood: comparison between 45,X monosomy and other Karyotypes","volume":"9","author":"Lebenthal","year":"2018","journal-title":"Front Endocrinol"},{"issue":"4","key":"2026031705574403300_bvag016-B8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1365-2265.1998.00552.x","article-title":"The impact of obesity on cardiovascular risk factors in Turner's syndrome","volume":"49","author":"Elsheikh","year":"1998","journal-title":"Clin Endocrinol"},{"issue":"9","key":"2026031705574403300_bvag016-B9","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1210\/jc.2009-0384","article-title":"X-chromosome gene dosage and the risk of diabetes in turner syndrome","volume":"94","author":"Bakalov","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031705574403300_bvag016-B10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fendo.2019.00049","article-title":"Glucose metabolism in turner syndrome","volume":"10","author":"Sun","year":"2019","journal-title":"Front Endocrinol"},{"issue":"5","key":"2026031705574403300_bvag016-B11","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/HYPERTENSIONAHA.120.15292","article-title":"Natural history of hypertension in turner syndrome during a 12-year pragmatic interventional study","volume":"76","author":"Sandahl","year":"2020","journal-title":"Hypertension"},{"issue":"6","key":"2026031705574403300_bvag016-B12","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/cen.12079","article-title":"An evaluation of early cardiometabolic risk factors in children and adolescents with turner syndrome","volume":"78","author":"O'Gorman","year":"2013","journal-title":"Clin Endocrinol"},{"issue":"8","key":"2026031705574403300_bvag016-B13","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1210\/jc.2006-0503","article-title":"Monosomy for the X-chromosome is associated with an atherogenic lipid profile","volume":"91","author":"Van","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026031705574403300_bvag016-B14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0022-3476(95)70551-1","article-title":"Lipid abnormalities in turner syndrome","volume":"126","author":"Ross","year":"1995","journal-title":"J Pediatr"},{"issue":"5","key":"2026031705574403300_bvag016-B15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1507\/endocrj.EJ15-0288","article-title":"Women with turner syndrome are at high risk of lifestyle-related disease -from questionnaire surveys by the foundation for growth science in Japan","volume":"63","author":"Hanew","year":"2016","journal-title":"Endocr J"},{"issue":"3","key":"2026031705574403300_bvag016-B16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/met.2013.0075","article-title":"Metabolic syndrome in turner syndrome and relation between body composition and clinical, genetic, and ultrasonographic characteristics","volume":"12","author":"Calcaterra","year":"2014","journal-title":"Metab Syndr Relat Disord"},{"issue":"12","key":"2026031705574403300_bvag016-B17","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMra030360","article-title":"Turner's syndrome","volume":"351","author":"Sybert","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"2026031705574403300_bvag016-B18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.eprac.2023.11.013","article-title":"Abnormal body composition increases the Cardiometabolic risk in adolescents and young adults with turner syndrome","volume":"30","author":"Mondal","year":"2024","journal-title":"Endocr Pract"},{"issue":"4","key":"2026031705574403300_bvag016-B19","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1530\/eje.1.02267","article-title":"Body composition is distinctly altered in turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules","volume":"155","author":"Gravholt","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2026031705574403300_bvag016-B20","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/sj.ijo.0802705","article-title":"The body mass index is a less-sensitive tool for detecting cases with obesity-associated co-morbidities in short stature subjects","volume":"28","author":"Lara-Esqueda","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"3","key":"2026031705574403300_bvag016-B21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1941738111404655","article-title":"Body mass index and percentage of body fat as indicators for obesity in an adolescent athletic population","volume":"3","author":"Etchison","year":"2011","journal-title":"Sports Health"},{"issue":"3","key":"2026031705574403300_bvag016-B22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41574-019-0310-7","article-title":"Waist circumference as a vital sign in clinical practice: a consensus statement from the IAS and ICCR working group on Visceral obesity","volume":"16","author":"Ross","year":"2020","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"2026031705574403300_bvag016-B23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/ijpo.263","article-title":"Bioelectrical impedance as a measure of change in body composition in young children","volume":"10","author":"Meredith-Jones","year":"2015","journal-title":"Pediatr Obes"},{"issue":"11","key":"2026031705574403300_bvag016-B24","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.2337\/diabetes.50.11.2444","article-title":"Longitudinal study on pubertal insulin resistance","volume":"50","author":"Goran","year":"2001","journal-title":"Diabetes"},{"key":"2026031705574403300_bvag016-B25"},{"key":"2026031705574403300_bvag016-B26"},{"issue":"4","key":"2026031705574403300_bvag016-B27","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jocd.2013.08.018","article-title":"The official positions of the international society for clinical densitometry: body composition analysis reporting","volume":"16","author":"Petak","year":"2013","journal-title":"J Clin Densitom"},{"issue":"Supplement_5","key":"2026031705574403300_bvag016-B28","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1542\/peds.2009-2107C","article-title":"Expert panel on integrated guidelines for Cardiovascular health and risk reduction in children and adolescents; national heart, lung, and blood institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report","volume":"128","author":"Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute","year":"2011","journal-title":"Pediatrics"},{"issue":"5","key":"2026031705574403300_bvag016-B29","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1210\/jc.2004-1939","article-title":"Excess visceral and hepatic adipose tissue in turner syndrome determined by magnetic resonance imaging: estrogen deficiency associated with hepatic adipose content","volume":"90","author":"Ostberg","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2026031705574403300_bvag016-B30","doi-asserted-by":"crossref","first-page":"e7038","DOI":"10.1371\/journal.pone.0007038","article-title":"Dual energy X-ray absorptiometry body composition reference values from NHANES","volume":"4","author":"Kelly","year":"2009","journal-title":"PLoS One"},{"issue":"160","key":"2026031705574403300_bvag016-B31","first-page":"1","article-title":"Mean body weight, height, Waist circumference, and body mass Index amoung children and adolescents: united States, 1999-2018","author":"Fryar","year":"2021","journal-title":"Natl Health Stat Report"},{"issue":"39","key":"2026031705574403300_bvag016-B32","first-page":"1","article-title":"Anthropometric reference data for children and adults: united States, 2011-2014","author":"Fryar","year":"2016","journal-title":"Vital Health Stat 3 Anal Stud"},{"key":"2026031705574403300_bvag016-B33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cyto.2018.06.026","article-title":"The correlation between serum adipokines levels and metabolic indicators in girls with turner syndrome","volume":"113","author":"Zhang","year":"2019","journal-title":"Cytokine"},{"issue":"5","key":"2026031705574403300_bvag016-B34","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1210\/jc.2004-1966","article-title":"Adipokine dysregulation in turner syndrome: comparison of circulating interleukin-6 and leptin concentrations with measures of adiposity and C-reactive protein","volume":"90","author":"Ostberg","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"2026031705574403300_bvag016-B35","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1001\/jama.282.22.2131","article-title":"Elevated C-reactive protein levels in overweight and obese adults","volume":"282","author":"Visser","year":"1999","journal-title":"JAMA"},{"issue":"3","key":"2026031705574403300_bvag016-B36","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.286.3.327","article-title":"C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus","volume":"286","author":"Pradhan","year":"2001","journal-title":"JAMA"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvag016\/66588853\/bvag016.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/4\/bvag016\/66588853\/bvag016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/4\/bvag016\/66588853\/bvag016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T09:57:51Z","timestamp":1773741471000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvag016\/8442142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3,6]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvag016","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,1,27]]},"article-number":"bvag016"}}